Herpes zoster and postherpetic neuralgia

References

• Wood MJ. History of varicella zoster virus. Herpes7(3), 60–65 (2000).
   PubMedGoogle Scholar
• Oxman MN, Levin MJ, Johnson GR et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med.352, 2271–2284 (2005).
   PubMed Web of Science ®Google Scholar
• Straus SE, Oxman MN. Varicella and herpes zoster. In: Fitzpatrick’s Dermatologyin General Medicine (5th Edition). Freedberg IM, Eisen AZ, Wolff K et al. (Eds). McGraw-Hill, NY, USA, 2427–2450 (1999).
   Google Scholar
• Opstelten W, Van Essen GA, Schellevis F, Verheij TJ, Moons K. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann. Epidmiol.16(9), 692–695 (2006).
   PubMed Web of Science ®Google Scholar
• Hope-Simpson RE. The nature of herpes zoster: a long-term study and new hypothesis. Proc. Roy. Soc. Med.58, 9–12 (1965).
   PubMedGoogle Scholar
• Brisson M, Edmunds WJ, Law B et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol. Infect.127, 305–314 (2001).
   PubMed Web of Science ®Google Scholar
• Thomas SL, Hall AF. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect. Dis.4, 26–32 (2004).
   PubMed Web of Science ®Google Scholar
• Schmader K. Herpes zoster in older adults. Aging Infect. Dis.32, 1481–1486 (2001).
   Web of Science ®Google Scholar
• Hope-Simpson RE. Some early investigations into the nature of herpes zoster and postherpetic neuralgia. In: Herpes Zoster and Postherpetic Neuralgia (2nd Edition). Watson CPN, Gershon AA (Eds). Elsevier, Amsterdam, The Netherlands (2001).
   Google Scholar
• Schmader KE. Epidemiology of herpes zoster. In: Varicella-Zoster Virus: Virology and Clinical Management. Arvin AM, Gershon AA (Eds). Cambridge University Press, Cambridge, UK, 220–245 (2000).
   Google Scholar
• Gershon AA, Mervish N, LaRussa P et al. Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection. J. Infect. Dis.176, 1496–1500 (1997).
   PubMed Web of Science ®Google Scholar
• Jacobson MA, Berger TG, Fikrig S et al. Acyclovir-resistant variecella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med.112, 187–191 (1990).
   PubMed Web of Science ®Google Scholar
• McNulty A, Li Y, Radtke U et al. Herpes zoster and the stage and prognosis of HIV-1 infection. Genitourin. Med.73, 467–470 (1997).
   PubMedGoogle Scholar
• Holmberg SD, Buchbinder SP, Conley LJ et al. The spectrum of medical conditions and symptoms before acquired immunodeficiency syndrome in homosexual and bisexual men infected with the immunodeficiency virus. Am. J. Epidemiol.141(5), 395–403 (1995).
   PubMed Web of Science ®Google Scholar
• Veenstra J, Krol A, van Praag RM et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS9, 1153–1158 (1995).
   PubMed Web of Science ®Google Scholar
• Chaisson RE, Gallant JE, Keruly JC, Moore RD. Impact of opportunistic disease on survival in patients with HIV infection. AIDS12, 29–33 (1998).
   PubMed Web of Science ®Google Scholar
• Gupta S, Jain A, Gardniner C, Tyring SK. A rare case of disseminated cutaneous zoster in an immunocompetent patient. BMC Fam. Pract.6, 50 (2005).
   PubMedGoogle Scholar
• Guinee VF, Guido JJ, Pfalzgraf KA et al. The incidence of herpes zoster in patients with Hodgkin’s disease. Cancer56, 642–648 (1985).
   PubMed Web of Science ®Google Scholar
• Butinx F, Wachanna R, Bartholomeeusen S, Sweldens K, Geys H. Is herpes zoster a marker for occult or subsequent malignancy? Br. J. Gen. Pract.55(511), 102–107 (2005).
   PubMed Web of Science ®Google Scholar
• Sawyer MH, Chamberlin CJ, Wu YN et al. Detection of varicella-zoster virus DNA in air samples from hospital rooms. J. Infect. Dis.169, 91–94 (1994).
   PubMed Web of Science ®Google Scholar
• Ruyechan WT, Hay J. DNA replication. In: Varicella-Zoster Virus: Virology and Clinical Management. Arvin AM, Gershon AA (Eds). Cambridge University Press, Cambridge, UK, 51–73 (2000).
   Google Scholar
• Arvin AM. Varicella-zoster virus. In: Fields Virology (4th Edition Vol. 2).Knipe DM, Howley PM (Eds). Lippincott Williams & Wilkins, PA, USA, 2731–2767 (2001).
   Google Scholar
• Silverstein S, Straus SE. Pathogenesis of latency and reactivation. In: Varicella-Zoster Virus: Virology and Clinical Management. Arvin AM, Gershon AA (Eds). Cambridge University Press, Cambridge, UK, 123–141 (2000).
   Google Scholar
• Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet360(9334), 678–682 (2002).
   PubMed Web of Science ®Google Scholar
• Oberg G, Svedmyr A. Varicelliform eruptions in herpes zoster – some clinic and serological observations. Scand. J. Infect. Dis.1, 47–49 (1969).
   PubMedGoogle Scholar
• Gilden DH, Dueland AN, Devlin ME et al. Varicella-zoster virus reactivation without rash. J. Infect. Dis.166, S30–S34 (1992).
   Google Scholar
• Oxman MN. Clinical manifestations of herpes zoster. In: Varicella-Zoster Virus: Virology and Clinical Management. Arvin AM, Gershon AA (Eds). Cambridge University Press, Cambridge, UK, 246–275 (2000).
   Google Scholar
• Pavan-Langston D. Ophthalmic zoster. In: Varicella-Zoster Virus: Virology and Clinical Management.Arvin AM, Gershon AA (Eds). Cambridge University Press, Cambridge, UK, 276–298 (2000).
   Google Scholar
• Juel-Jensen B, MacCallum F. Herpes Simplex, Varicella and Zoster: Clinical Manifestations and Treatment. JB Lippincott, PA, USA (1972).
   Google Scholar
• Harding SP, Lipton JR, Wells JC. Natural history of herpes zoster ophthalmicus: predictors of postherpetic neuralgia and ocular involvement. Br. J. Ophthalmol.72(5), 353–358 (1987).
   Google Scholar
• Zaal MJ, Volker-Dieben HJ, D’Amaro J. Prognostic value of Hutchinson’s sign in acute herpes zoster ophthalmicus. Graefes Arch. Clin. Exp. Ophthalmol.241(3), 187–191 (2003).
   PubMed Web of Science ®Google Scholar
• Rübben A, Baron JM, Grussendorf-Conen EI. Routine detection of herpes simplex virus and varicella zoster virus by polymerase chain reaction reveals that initial herpes zoster is frequently misdiagnosed as herpes simplex. Br. J. Dermatol.137, 259–261 (1997).
   PubMed Web of Science ®Google Scholar
• Kalman CM, Laskin OL. Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Am. J. Med.81(5), 775–778 (1986).
   PubMed Web of Science ®Google Scholar
• Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH. Acute pain in herpes zoster and its impact on health-related quality of life. Clin. Infect. Dis.39, 342–348 (2004).
   PubMed Web of Science ®Google Scholar
• Erhard H, Rünger TM, Kreienkamp M, Müller J, Müller-Hermelink H-K, Bröcker E-B. Atypical varicella-zoster virus infection in an immunocompromised patient: result of a virus-induced vasculitis. J. Am. Acad. Dermatol.32, 908–911 (1995).
   PubMed Web of Science ®Google Scholar
• O’Toole EA, Mooney EE, Walsh JB, Sweeney EC, Barnes L. Disseminated herpes zoster in the elderly. Ir. J. Med. Sci.166(3), 141–142 (1997).
   PubMed Web of Science ®Google Scholar
• Gupta S, Jain A, Gardiner C, Tyring SK. A rare case of disseminated cutaneous zoster in an immunocompetent patient. BMC Fam. Pract.6, 50 (2005).
   PubMedGoogle Scholar
• Bennett GJ. Neuropathic pain: new insights, new interventions. Hops. Pract.33(10), 95–110 (1998).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Schmader KE. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Herpes Zoster and Postherpetic Neuralgia (2nd Edition). Watson CPN, Gershon AA (Eds). Elsevier Science VB, Amsterdam, The Netherlands, 11, 39–64 (2001).
   Google Scholar
• Coplan PM, Schmader K, Nikas A et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J. Pain5(6), 344–356 (2004).
   PubMed Web of Science ®Google Scholar
• Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin. J. Pain189, 350–354 (2002).
   Google Scholar
• Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine19, 3076–3090 (2001).
   PubMed Web of Science ®Google Scholar
• Lancaster T, Silagy C, Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br. J. Gen. Pract.45(390), 39–45 (1995).
   PubMed Web of Science ®Google Scholar
• De Moragas JM, Kierland RR. The outcome of patients with herpes zoster. Arch. Dermatol.75, 193–196 (1957).
   Web of Science ®Google Scholar
• Nagasako EM, Johnson RW, Griffin DRJ, Dworkin RH. Rash severity in herpes zoster: correlates and relationship to postherpetic neuralgia. J. Am. Acad. Dermatol.46, 834–839 (2002).
   PubMed Web of Science ®Google Scholar
• Watson CPN, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain44, 105–117 (1991).
   PubMed Web of Science ®Google Scholar
• Watson CPN, Oaklander Al, Deck JH. The neuropathology of herpes zoster with particular reference to postherpetic neuralgia and its pathogenesis. In: Herpes Zoster and Postherpetic Neuralgia (2nd Edition). Watson CPN, Gershon AA (Eds). Elsevier Science VB, Amsterdam, The Netherlands, 11, 167–182 (2001).
   Google Scholar
• Bowsher D. Pain, sensory change, and allodynia in postherpetic neuralgia. Herpes Zoster and Postherpetic Neuralgia (2nd Edition). Watson CPN, Gershon AA (Eds). Elsevier Science VB, Amsterdam, The Netherlands 11, 143–147 (2001).
   Google Scholar
• Van Seventer R, Sadosky A, Lucero M, Dukes E. A cross-sectional survey of health stae impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing35(2), 132–137 (2006).
   PubMed Web of Science ®Google Scholar
• Wood MJ, Easterbrook PJ. Clinician’s Manual on Herpes Zoster. Science Press, London, UK, 1–44 (1995).
   Google Scholar
• Stjernquist-Desatnik A, Skoog E, Aurelius E. Detection of herpes simplex and varicella-zoster viruses in patients with Bell’s palsy by the polymerase chain reaction technique. Ann. Otol. Rhinol. Laryngol.115(4), 306–311 (2006).
   PubMed Web of Science ®Google Scholar
• Devriese PP, Moesker WH. The natural history of facial paralysis in herpes zoster. Clin. Otolaryngol.13, 289–298 (1988).
   PubMed Web of Science ®Google Scholar
• Gray F, Bélec L, Lescs MC et al. Varicella-zoster virus infection of the central nervous system in the acquire immune deficiency syndrome. Brain117, 987–999 (1994).
   PubMed Web of Science ®Google Scholar
• Kleinschmidt-DeMasters BK, Amile-Lefond C, Gilden DM. The patterns of varicella-zoster virus encephalitis. Human Pathol.27, 927–938 (1996).
   PubMed Web of Science ®Google Scholar
• Dayan AD, Ogul E, Graveson GS. Polyneuritis and herpes zoster. J. Neurol. Neurosurg. Psychiatry47, 929–931 (1972).
   Google Scholar
• Gilden DH, LaGuardia JJ, Kleinschmidt-DeMasters BK. Postherpetic neuralgia and other neurologic complications. In: Varicella-Zoster Virus. Virology and Clinical Management. Arvin AM, Gershon AA (Eds). Cambridge University Press, Cambridge, UK, 299–316 (2000).
   Google Scholar
• Piebenga L, Laibson P. Dendritic lesions in herpes zoster ophthalmicus. Arch. Ophthalmol.90, 268–273 (1973).
   PubMedGoogle Scholar
• Liesegang T. Corneal complications from herpes zoster ophthalmicus. Ophthalmology92, 316 (1985).
   PubMed Web of Science ®Google Scholar
• Jarrett P, Ha F, Oliver F. Necrotizing fasciitis complicating disseminated cutaneous herpes zoster. Clin. Exp. Dermatol.23, 87–88 (1998).
   PubMed Web of Science ®Google Scholar
• Weller TH. Varicella-herpes zoster virus. In: Viral Infections of Humans: Epidemiology and Control (4th Edition). Evans AS, Kaslow RA (Eds). Plenum Publishing Co, NY, USA (1997).
   Google Scholar
• Enders G, Miller E. Varicella and herpes zoster in pregnancy and the newborn. In: Varicella-Zoster Virus: Virology and Clinical Management. Arvin AM, Gershon AA (Eds). Cambridge University Press, Cambridge, UK, 317–347 (2000).
   Google Scholar
• Enders G, Miller E, Cradock-Watson J et al. Consequences of varicella and herpes zoster in pregnancy: a prospective study of 1739 cases. Lancet343, 1547–1550 (1994).
   Google Scholar
• Higa K, Dan K, Manabe H. Varicella-zoster virus infections during pregnancy: hypothesis concerning the mechanisms of congenital malformations. Obstet. Gynecol.69, 214–222 (1987).
   PubMed Web of Science ®Google Scholar
• Miller E, Cradock-Watson JE, Ridehalgh MKS. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet2(8659), 372–373 (1989).
   Web of Science ®Google Scholar
• Forghani B. Laboratory diagnosis of infection. In: Varicella-Zoster Virus: Virology and Clinical Management. Arvin AM, Gershon AA (Eds). Cambridge University Press, Cambridge, UK, 351–382 (2000).
   Google Scholar
• Nahass GT, Penneys NS, Leonardi CL. Analysis of the polymerase chain reaction in the detection of herpes virus DNA from fixed and stained tissue sections. Arch. Dermatol.131, 805–808 (1995).
   PubMedGoogle Scholar
• Mounsey AL, Matthew LG, Slawson DC. Herpes zoster and postherpetic neuralgia: prevention and management. Am. Fam. Physician72(6), 1075–1080 (2005).
   PubMed Web of Science ®Google Scholar
• Opstelten W, Zaal MJW. Managing ophthalmic herpes zoster in primary care. Br. Med. J.331(7509), 147–151 (2005).
   PubMed Web of Science ®Google Scholar
• Cobo LM, Foulks GN, Liesengang T et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology93(6), 763–770 (1986).
   PubMed Web of Science ®Google Scholar
• Zaal MJ, Volker-Dieben HJ, Wienesen M, D’Amaro J, Kijlstra A. Longitudinal analysis of varicella-zoster virus DNA on the ocular surface associated with herpes zoster ophthalmicus. Am. J. Ophthalmol.131(1), 25–29 (2001).
   PubMed Web of Science ®Google Scholar
• Wood MJ, Ogan PH, McKendrick MW, Care CD, McGill JI, Webb EM. Efficacy of oral acyclovir treatment of acute herpes zoster. Am. J. Med.85(Suppl. 2A), 79–83 (1988).
   PubMed Web of Science ®Google Scholar
• Morton P, Thomson AN. Oral acyclovir in the treatment of herpes zoster in general practice. NZ Med. J.102, 93–95 (1989).
   PubMed Web of Science ®Google Scholar
• Wood MJ, Kay R, Dworkin RH, Soong S-J, Whitley RJ. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin. Infect. Dis.22, 341–347 (1996).
   PubMed Web of Science ®Google Scholar
• Alper BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia? A systematic review of the literature. J. Fam. Pract.49(3), 255–264 (2000).
   PubMed Web of Science ®Google Scholar
• Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N. Engl. J. Med.330, 896–900 (1994).
   PubMed Web of Science ®Google Scholar
• Harding SP, Porter SM. Oral acyclovir in herpes zoster ophthalmicus. Curr. Eye Res.10, S177–S182 (1991).
   PubMed Web of Science ®Google Scholar
• Tyring S, Engst R, Corriveau C et al. Famciclovir for ophthalmic zoster: a randomized acyclovir controlled study. Br. J. Ophthalmol.85, 576–581 (2001).
   PubMed Web of Science ®Google Scholar
• Dedicoat M, Wood M. Treatment of herpes zoster. In: Varicella-Zoster Virus: Virology and Clinical Management. Arvin AM, Gershon AA (Eds). Cambridge University Press, Cambridge, UK, 396–411 (2000).
   Google Scholar
• Palay DA, Sternberg P, Davis J et al. Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am. J. Ophthalmol.112, 250–255 (1991).
   PubMed Web of Science ®Google Scholar
• Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood ML. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob. Agents Chemother.39, 1546–1553 (1995).
   PubMed Web of Science ®Google Scholar
• Tyring S, Barbarash RA, Nahlik JE et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. Ann. Intern. Med.123, 89–96 (1995).
   Google Scholar
• Degreef H. Famciclovir herpes zoster clinical study group. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int. J. Antimicrob. Agents4, 241–246 (1994).
   PubMed Web of Science ®Google Scholar
• Figueroa MS, Garibito I, Gutierrez C, Fortun J. Famciclovir for the treatment of acute retinal necrosis (ARN) syndrome. Am. J. Ophthalmol.123, 255–257 (1997).
   PubMed Web of Science ®Google Scholar
• Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch. Fam. Med.9(9), 863–869 (2000).
   PubMedGoogle Scholar
• Whitley RJ, Weiss H, Gnann JW Jr et al. Acyclovir with and without prednisolone for the treatment of herpes zoster. Ann. Intern. Med.125, 376–383 (1996).
   PubMed Web of Science ®Google Scholar
• Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J. Pain Symptom Manage.13, 327–331 (1997).
   PubMed Web of Science ®Google Scholar
• Pasqualucci A, Pasqualucci V, Galla F et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta. Anaesthesiol. Scand.44(8), 910–918 (2000).
   PubMed Web of Science ®Google Scholar
• Kumar V, Krone K, Mathieu A. Neuraxial and sympathetic blocks in herpes zoster and postherpetic neuralgia: an appraisal of current evidence. Reg. Anesth. Pain Med.29(5), 454–461 (2004).
   PubMed Web of Science ®Google Scholar
• Van Wijck AJ, Opstelten W, Moons KG et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomized controlled trial. Lancet367(9506), 219–224 (2006).
   PubMed Web of Science ®Google Scholar
• Watson CP, Tyler KL, Bickers DR, Millikan LE, Smith S, Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin. Ther.15, 510–526 (1993).
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain65(1), 39–44 (1996).
   PubMed Web of Science ®Google Scholar
• Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology50(6), 1837–1841 (1998).
   PubMed Web of Science ®Google Scholar
• Watson CP, Vernich L, Chipman M, Reed K. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology51(4), 1155–1171 (1998).
   Google Scholar
• Raja SN, Haythornthwaite JA, Pappagallo M et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized placebo-controlled trial. Neurology59, 1015–1021 (2002).
   PubMed Web of Science ®Google Scholar
• Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA280(21), 1837–1842 (1998).
   PubMed Web of Science ®Google Scholar
• Rice AS, Maton S. Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain94(2), 215–224 (2001).
   PubMed Web of Science ®Google Scholar
• Gilron I, Bailey JM, Tu D et al. Morphine, gabapentin, or their combination for neuropathic pain. N. Engl. J. Med.352, 1324–1334 (2005).
   PubMed Web of Science ®Google Scholar
• Van Seventer R, Feister HA, Young JP Jr, Stoker M, Versavel M, Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr. Med. Res. Opin.22(2), 375–384 (2006).
   PubMed Web of Science ®Google Scholar
• Kotani N, Kushikata T, Hashimoto H, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N. Engl. J. Med.343, 1514–1519 (2000).
   PubMed Web of Science ®Google Scholar
• Kikuchi A, Kotani N, Sato T, Takamura K, Sakai I, Matsuki A. Comparative therapeutic evaluation of intrathecal versus epidural methylprednisolone for long-term analgesia in patients with intractable postherpetic neuralgia. Reg. Anesth. Pain Med.24, 287–293 (1999).
   PubMed Web of Science ®Google Scholar
• Gelb LD, Dohner DE, Gershon AA et al. Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults. J. Infect. Dis.155, 633–640 (1987).
   PubMed Web of Science ®Google Scholar
• Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vacination-associated decreases in the incidence of varicella, 1992–2002. J. Infect. Dis.191, 2002–2007 (2005).
   PubMed Web of Science ®Google Scholar